newsfilter
← Latest News
PR Newswire·

Seelos Therapeutics, Inc. Releases Letter to its Stockholders

Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos"), a clinical-stage biopharmaceutical company focused on the development of therapies for central...